Get the Stockscreener App
1.625
4.77%
-0.0814
After Hours:
1.84
0.215
+13.23%
Aditxt Inc stock is traded at $1.625, with a volume of 381.36K.
It is down -4.77% in the last 24 hours and down -86.14% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
See More
Previous Close:
$1.7064
Open:
$1.9
24h Volume:
381.36K
Relative Volume:
4.82
Market Cap:
$1.47M
Revenue:
$3,200
Net Income/Loss:
$-42.79M
P/E Ratio:
-0.000216
EPS:
-7534.7458
Net Cash Flow:
$-25.70M
1W Performance:
-44.89%
1M Performance:
-86.14%
6M Performance:
-99.82%
1Y Performance:
-100.00%
1-Day Range:
$1.41
$1.93
1-Week Range:
$1.41
$2.97
52-Week Range:
$1.41
$53,451.08
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.625 | 57,162 | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
436.58 | 110.90B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
629.68 | 73.20B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
776.26 | 49.71B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.27 | 38.32B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
144.37 | 30.97B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aditxt Inc Stock (ADTX) Latest News
Nasdaq Down 200 Points; Brady Earnings Top Views - Benzinga
ADTX stock crashes over 20% after third reverse split in 7 months – retail calls the decline 'unreasonable' - MSN
Aditxt Enacts Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Aditxt Signals Brief Delay in Quarterly Filing - TipRanks
Aditxt (NASDAQ: ADTX) sets 1-for-27 reverse split, cutting shares to ~510K - Stock Titan
Aditxt (ADTX) files Rule 12b-25; Q1 2026 10-Q to follow - Stock Titan
Aditxt, Inc.Common Stock (NQ: ADTX - The Chronicle-Journal
ADTX Stock Crashes Over 20% After Third Reverse Split In 7 Months – Retail Calls The Decline ‘Unreasonable’ - Stocktwits
Aditxt Announces 1-for-27 Reverse Stock Split to Meet Nasdaq Listing Requirement - MEXC
Aditxt to implement 1-for-27 reverse stock split on May 18 By Investing.com - Investing.com South Africa
Aditxt Announces 1-For-27 Reverse Stk Split >ADTX - Moomoo
Aditxt, Inc. announces 1-for-27 reverse stock split effective at the open of trading on May 18, 2026 - marketscreener.com
Aditxt to implement 1-for-27 reverse stock split on May 18 - Investing.com
Aditxt, Inc. Announces 1-For-27 Reverse Stock Split Effective At The Open Of Trading On May 18, 2026 - TradingView
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 - FinancialContent
TradingKey - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aditxt Faces Nasdaq Delisting After Extended Bid-Price Noncompliance - The Globe and Mail
Aditxt, Inc. Receives Nasdaq Delisting Notice on May 6, 2026 – Form 8-K Filing Disclosure - Minichart
Nasdaq moves to delist Aditxt (NASDAQ: ADTX) after $1 bid-price violation - Stock Titan
MSN Money - MSN
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
ADTX - Finviz
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
Aditxt, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Nasdaq Listing Information - Minichart
Aditxt Shareholders Approve Reverse Split and Governance Measures - The Globe and Mail
Aditxt (ADTX) investors approve reverse split authority and elect full board - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HRT Financial LP sells $9,338 in Aditxt stock By Investing.com - Investing.com Australia
HRT Financial LP sells $9,338 in Aditxt stock - Investing.com
HRT Financial LP trims Aditxt (NASDAQ: ADTX) stake with open-market sales - Stock Titan
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
HRT Financial buys $24,060 Aditxt shares, sells $3,594 By Investing.com - Investing.com India
148.3M Warrant Shares Registered for Resale by Aditxt (NASDAQ: ADTX) - Stock Titan
HRT Financial buys $24,060 Aditxt shares, sells $3,594 - Investing.com
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):